JULIE YANG: Open Payments
NPI 1861825960 · COMPTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 13 payments from 8 companies in 2025. Trend: 2023 $1,189 · 2024 $2,149 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $173 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Janssen Pharmaceuticals, Inc | 1 | $39 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $27 |
| Alkermes, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $17 |
| Tris Pharma Inc | 1 | $16 |
Products named: CAPLYTA, REXULTI, SPRAVATO, ABILIFY MAINTENA, Auvelity, VRAYLAR, ARISTADA, Dyanavel XR.
Industry payments across CA — which companies pay providers there.
